- Treatment and prevention of postmenopausal osteoporosis
- Treatment to increase bone mass in men with osteoporosis
- Treatment and prevention of glucocorticoid-induced osteoporosis
- Treatment of Paget’s disease of bone in men and women
NATL
OR
OR
OR
Drug | Dosing Regimen | Dose Limit/ Maximum Dose |
---|---|---|
alendronate (FosamaxR) | Post menopausal Osteoporosis (PMO) prevention 5 mg PO QD or 35 mg PO once weekly PMO treatment 10 mg PO QD or 70 mg once weekly Male osteoporosis treatment 10 mg PO QD or 70 mg PO once weekly GIO treatment Paget's disease5 mg PO QD or 10 mg PO QD (in postmenopausal women not receiving estrogen) 40 mg PO QD for 6 months | Osteoporosis Paget's Disease10 mg/day or 70 mg/week 40 mg/day for 6 months |
Fosamax Plus DR (alendronate/ cholecalciferol) * | PMO treatment and Male osteoporosis treatment | 70 mg alendronate/5,600 units cholecalciferol/week |
risedronate (ActonelR)* | PMO prevention & treatment: 5 mg PO QD or 35 mg PO once weekly or 150 mg PO once monthly Male osteoporosis treatment: 35 mg PO once weekly GIO prevention & treatment: 5 mg PO QD B. Paget’s disease: 30 mg PO QD for 2 months | Osteoporosis 5 mg/day 35 mg/week 150 mg/month Paget's Disease30 mg/day for 2 months |
ibandronate (BonivaR)* | PMO prevention & treatment (tablets): 150 mg PO once monthly PMO treatment (injection): 3 mg IV every 3 months over 15 to 30 seconds | PO: 150 mg/month IV: 3 mg per dose once every 3 months |
raloxifene (EvistaR) | PMO prevention & treatment 60 mg PO QD | 60 mg/day |
calcitonin-salmon nasal spray (MiacalcinR, ForticalR Nasal Spray) | PMO treatment | Nasal Spray: 200 IU/day |
ForteoR (teriparatide) * | PMO treatment, GIO treatment, Male osteoporosis treatment 20 mcg SC QD | 20 mcg/day for a maximum of 2 years |
ProliaTM (denosumab) * | PMO treatment, Male osteoporosis treatment: 60 mg SC every 6 months Prolia should be administered by a healthcare professional. | 60 mg per dose once every 6 months |
MiacalcinR Injection (calcitonin -salmon) * | PMO treatment 100 IU SC/IM every QOD Treatment of Paget's Disease 100 IU SC/IM QD | Injection: 100 IU/day |
etidronate disodium (DidronelR) | Treatment of Paget's Disease Initial treatment: 5-10 mg/kg/day PO not to exceed 6 months or 11-20 mg/kg/day PO not to exceed 3 months | 20 mg/kg/day Re-treatment should occur only after a drug-free period of at least 3 months, |
pamidronate disodium (ArediaR) | Treatment of Paget's Disease 30 mg daily as a 4-hour IV infusion on 3 consecutive days for a total dose of 90 mg | 30 mg/day |
Drug | Dosing Regimen | Authorization Limit |
---|---|---|
Reclast | Treatment of Paget's Disease 5 mg IV infusion over at least 15 minutes for one dose PMO Treatment; Male osteoporosis treatment and GIO prevention and treatment 5 mg IV infusion over at least 15 minutes once a yearPMO Prevention 5 mg IV infusion over at least 15 minutes once every two years | Treatment of Paget's Disease: |
Injection: 5 mg/100 ml bottle
1. Reclast [Prescribing Information] East Hanover, NJ: Novartis Pharmaceuticals Corp.; April 2015.
2. National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. Available at: http://nof.org/files/nof/public/content/file/2791/upload/919.pdf. Accessed February 25, 2016.
3. The North American Menopause Society. Management of osteoporosis in postmenopausal women: 2010 position statement of the North American Menopause Society. Menopause2010;17(1):22-54.
4. Watts NB, Bilezikian JP, Camacho PM, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of postmenopausal osteoporosis. Endocr Pract 2010;16(Suppl 3):1-37.
5. Grossman JM, Gordon R, Ranganath VK, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res 2010;62(11):1515-1526.
6. Zoledronic acid. American Hospital Formulary Service Drug Information. Available at: http://www.medicinescomplete.com/mc/ahfs.current/. Accessed February 25, 2016.
7. MicromedexR Healthcare Series [Internet database]. Greenwood Village, Colo: Thomson Healthcare. Updated periodically. Accessed February 25, 2016.
8. Clinical Pharmacology Web site. Available at http://cpip.gsm.com/. Accessed February 25, 2016.